-
Revisão
Hormonal contraception and antiretroviral therapy among HIV-infected women
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(11):680-684
02-12-2006
Summary
RevisãoHormonal contraception and antiretroviral therapy among HIV-infected women
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(11):680-684
02-12-2006DOI 10.1590/S0100-72032006001100008
Views57There is much controversy regarding the realtionship between the use of hormonal contraceptives and the risk of acquiring human immunodeficiency virus (HIV), and little is known about the effects of hormonal contraception in HIV-infected women (adverse events, menstrual disorders, disease progression, antiretroviral therapy interactions). The aim of the present study was to review available data regarding HIV vulnerability and transmission associated with hormonal contraceptives and the use of these contraceptives by women on antiretroviral therapy, with emphasis on drug interactions. In conclusion, it was not possible to offer evidence-based recommendations for the use of hormonal contraceptives among HIV-infected women under antiretroviral therapy. Infectious disease specialists and gynecologists providing care should be cautious about potential drug interaction leading to increase in adverse events, individualizing contraceptive drugs, route, and dosage, according to the antiretroviral therapy under use.
Key-words Antiretroviral therapy, highly activeContraceptionContraceptives, oral, hormonalHIVHIV infectionsSee moreViews57
This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Summary
RevisãoHormonal contraception and antiretroviral therapy among HIV-infected women
Revista Brasileira de Ginecologia e Obstetrícia. 2006;28(11):680-684
02-12-2006DOI 10.1590/S0100-72032006001100008
Views57There is much controversy regarding the realtionship between the use of hormonal contraceptives and the risk of acquiring human immunodeficiency virus (HIV), and little is known about the effects of hormonal contraception in HIV-infected women (adverse events, menstrual disorders, disease progression, antiretroviral therapy interactions). The aim of the present study was to review available data regarding HIV vulnerability and transmission associated with hormonal contraceptives and the use of these contraceptives by women on antiretroviral therapy, with emphasis on drug interactions. In conclusion, it was not possible to offer evidence-based recommendations for the use of hormonal contraceptives among HIV-infected women under antiretroviral therapy. Infectious disease specialists and gynecologists providing care should be cautious about potential drug interaction leading to increase in adverse events, individualizing contraceptive drugs, route, and dosage, according to the antiretroviral therapy under use.
Key-words Antiretroviral therapy, highly activeContraceptionContraceptives, oral, hormonalHIVHIV infectionsSee moreThis is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Contraceptives, oral, hormonal Archives - Revista Brasileira de Ginecologia e Obstetrícia
